Expanding the institute’s global presence in vaccine production is on the agenda, said Hamid Kahram, head of Razi Vaccine & Serum Research Institute.
Razi Institute with its long history in vaccine production seeks to strengthen its place among other competitive manufacturers.
Science and technology infrastructure development, supporting science-based private companies, and encouraging investments in this sector, are among the institute’s development plans.
With implementation of the plans, it is expected that Iran can meet 10% of the global market requirement in vaccine production till 2025.
